ANTHRAQUINONE-2-CARBOXYLIC ACID

CAS No. 117-78-2

ANTHRAQUINONE-2-CARBOXYLIC ACID( —— )

Catalog No. M17856 CAS No. 117-78-2

Anthraquinone-2-carboxylic acid acts as a potent anti-inflammatory and antinociceptive component in vivo, thus contributing to the immune regulatory role of fruits and herbs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 45 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ANTHRAQUINONE-2-CARBOXYLIC ACID
  • Note
    Research use only, not for human use.
  • Brief Description
    Anthraquinone-2-carboxylic acid acts as a potent anti-inflammatory and antinociceptive component in vivo, thus contributing to the immune regulatory role of fruits and herbs.
  • Description
    Anthraquinone-2-carboxylic acid acts as a potent anti-inflammatory and antinociceptive component in vivo, thus contributing to the immune regulatory role of fruits and herbs.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    IRAK-1| Syk
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    117-78-2
  • Formula Weight
    252.22
  • Molecular Formula
    C15H8O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (99.12 mM)
  • SMILES
    c1ccc2c(c1)C(=O)c1c(C2=O)cc(cc1)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Park JG,et al. Anti-Inflammatory and Antinociceptive Activities of Anthraquinone-2-Carboxylic Acid.Mediators Inflamm. 2016;2016:1903849.
molnova catalog
related products
  • Dolutegravir interme...

    Dolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2.

  • Tenofovir alafenamid...

    Tenofovir alafenamide fumarate (GS-7340 fumarate) is an orally available precursor of Tenofovir with anti-HIV activity, used to prevent HIV infection.

  • DRB

    DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II (IC50 range of 4-10 μM).